drugset / Trial / NCT01633359

The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

NCT01633359 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

Hypothesis: Peripheral blood Very Small Embryonic-like Stem Cells (VSELs) are different in coronary artery disease (CAD) patients from those without CAD, which might account for the benefits of Atorvastatin in CAD patients.

Timeline

Start
2012-07
Primary completion
2012-12
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg —